Browsing Tag
Kala Bio Inc.
1 post
Kala Bio launches $10m registered direct financing amid balance sheet reset and dilution concerns
Find out how Kala Bio’s $10 million at-the-market stock offering under Nasdaq rules is reshaping its balance sheet, dilution risk, and survival strategy.